Life Sciences

NuVascular Technologies is sitting at the intersection of health care and textiles, a startup that's developing such products as artificial blood vessels. Matt Phaneuf, who has worked in medical research for 25 years, co-founded NuVascular.

ReWalk Robotics of Marlborough reported a 277 percent year-over-year revenue jump to $1.5 million.

Marlborough-based RXi Pharmaceuticals, which is working on a drug to reduce dermal scarring after surgery, reported financial results for the quarter ended Sept. 30.

Medical device manufacturer Arrhythmia Research Technology of Fitchburg (NYSE:HRT) turned in its third straight profitable quarter as revenue jumped nearly 28 percent over the third quarter of 2013, the company announced Wednesday.

Medical device manufacturer SeraCare Life Sciences of Milford has been slapped with a $6,621 penalty over alleged violations of state hazardous waste management regulations, the Mass. Department of Environmental Protection (DEP) announced. During a May 2014 inspection, DEP personnel determined that SeraCare stored hazardous waste for longer than allowed, failed to properly label hazardous waste containers, clearly designate its hazardous waste accumulation area and keep a record of inspections conducted on its hazardous waste accumulation area, a DEP statement said.

If there's one clear economic development legacy Gov. Deval Patrick will leave behind after eight years in...

Less than two weeks after abandoning a $55 billion deal to buy rival Shire following changes to U.S. tax rules, Illinois-based drug maker AbbVie raised its annual earnings guidance after sales of its top drug grew 17 percent.

Harvard Bioscience Inc. said a weaker U.S. dollar compared to the British pound helped bump its third quarter revenues slightly.

Driven by what it termed “record sales” of it its Ventricular Assist Systems, Framingham-based HeartWare International on Thursday announced its run of solid revenue performance had extended to the third quarter.

The University of Massachusetts Medical School in Worcester will partner with Atlanta-based medical device firm LumaMed in a joint clinical study to evaluate the effectiveness of an imaging platform used in breast cancer surgery, and possibly other types of cancer surgeries.